INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 43 filers reported holding INFLARX NV in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,889,678 | -32.7% | 634,120 | +0.7% | 0.00% | – |
| Q2 2023 | $2,809,443 | +124.5% | 629,920 | -2.3% | 0.00% | – |
| Q1 2023 | $1,251,362 | -37.8% | 645,032 | -0.6% | 0.00% | – |
| Q4 2022 | $2,010,759 | +9.5% | 648,632 | -6.7% | 0.00% | – |
| Q3 2022 | $1,836,000 | +64.7% | 695,377 | -9.5% | 0.00% | – |
| Q2 2022 | $1,115,000 | -19.4% | 768,732 | +1.7% | 0.00% | – |
| Q1 2022 | $1,384,000 | -66.7% | 756,032 | -13.5% | 0.00% | -100.0% |
| Q4 2021 | $4,159,000 | +122.1% | 873,661 | +20.8% | 0.00% | – |
| Q3 2021 | $1,873,000 | -16.0% | 722,975 | -3.8% | 0.00% | – |
| Q2 2021 | $2,231,000 | -20.7% | 751,293 | +4.2% | 0.00% | – |
| Q1 2021 | $2,812,000 | -20.8% | 720,977 | +2.1% | 0.00% | -100.0% |
| Q4 2020 | $3,552,000 | +36.0% | 706,142 | +15.2% | 0.00% | 0.0% |
| Q3 2020 | $2,612,000 | +52.0% | 613,062 | +63.8% | 0.00% | – |
| Q2 2020 | $1,718,000 | +325.2% | 374,224 | +253.7% | 0.00% | – |
| Q1 2020 | $404,000 | -88.7% | 105,817 | -88.3% | 0.00% | -100.0% |
| Q4 2019 | $3,574,000 | +41.6% | 902,381 | -11.7% | 0.00% | 0.0% |
| Q3 2019 | $2,524,000 | +136.8% | 1,021,719 | +203.0% | 0.00% | – |
| Q2 2019 | $1,066,000 | -53.6% | 337,247 | +454.5% | 0.00% | -100.0% |
| Q1 2019 | $2,299,000 | +111.7% | 60,823 | +103.7% | 0.00% | – |
| Q4 2018 | $1,086,000 | -35.1% | 29,862 | -38.8% | 0.00% | – |
| Q3 2018 | $1,673,000 | +6.2% | 48,755 | -0.2% | 0.00% | – |
| Q2 2018 | $1,575,000 | +8189.5% | 48,845 | +5327.2% | 0.00% | – |
| Q4 2017 | $19,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,766,038 | $56,955,000 | 17.85% |
| RA Capital Management | 1,967,148 | $63,441,000 | 4.12% |
| Cormorant Asset Management, LP | 1,487,265 | $47,964,000 | 3.55% |
| Redmile Group, LLC | 2,027,700 | $65,393,000 | 2.22% |
| EMORY UNIVERSITY | 77,554 | $2,501,000 | 1.66% |
| Eventide Asset Management | 275,000 | $8,869,000 | 0.37% |
| Birchview Capital, LP | 16,000 | $516,000 | 0.35% |
| Artal Group S.A. | 500,000 | $16,125,000 | 0.34% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,385,659 | $76,938,000 | 0.18% |
| Baker Brothers Advisors | 258,824 | $8,347,000 | 0.06% |